New Data Support Move to Single-Tablet Darunavir-Based Regimen for Treating HIV
August 3rd 2018New research demonstrates continued virologic control in patients with HIV-1 following a switch to Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg [D/C/F/TAF]) regardless of prior treatment regimen
Read More
Low-Dose Fenfluramine Successful in Treating Dravet Syndrome in Phase 3 Trial
August 1st 2018Fenfluramine, a drug that was previously sold as an appetite suppressant before it was withdrawn from the market in 1997 over concerns about its link to heart valve problems, may have a new application.
Read More